Sight Sciences, Inc.

The momentum for this stock is not very good. Sight Sciences, Inc. is not a good value stock. Sight Sciences, Inc. is a mediocre stock to choose.

News

Financial Comparison: Sight Sciences (NASDAQ:SGHT) vs. Accuray (NASDAQ:ARAY)

Zolmax Sight Sciences (NASDAQ:SGHT - Get Free Report) and Accuray (NASDAQ:ARAY - Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two businesses...\n more…

Sight Sciences (NASDAQ:SGHT) Now Covered by Lake Street Capital

Ticker Report Analysts at Lake Street Capital began coverage on shares of Sight Sciences (NASDAQ:SGHT - Get Free Report) in a research note issued on Wednesday, StockNewsAPI reports. The brokerage set a "buy...\n more…

Sight Sciences Poised for Growth: Buy Rating Affirmed Amid Market Expansion and Favorable Reimbursement Outlook

TipRanks Financial Blog Frank Takkinen, an analyst from Lake Street, has initiated a new Buy rating on Sight Sciences (SGHT). Frank Takkinen has given his Buy rating due t...\n more…

Sight Sciences to Present at the Upcoming Morgan Stanley Global Healthcare Conference

Globe Newswire MENLO PARK, Calif., Aug. 20, 2024 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) ("Sight Sciences" or the "Company"), an eyecare technology company focused on developing and...\n more…

Sight Sciences, Inc. (NASDAQ:SGHT) Receives $5.70 Average PT from Analysts

Ticker Report Shares of Sight Sciences, Inc. (NASDAQ:SGHT - Get Free Report) have been assigned a consensus recommendation of "Hold" from the seven ratings firms that are presently covering the stock, Marketbeat...\n more…

Why We're Not Concerned Yet About Sight Sciences, Inc.'s (NASDAQ:SGHT) 26% Share Price Plunge

Simply Wall St Sight Sciences, Inc. ( NASDAQ:SGHT ) shares have had a horrible month, losing 26% after a relatively good period...\n more…